NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Position in MYGN — Myriad Genetics Inc
CIK 921739
PHILADELPHIA, PA
Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$225,000
-$82,500 QoQ
Shares Held
50,000
0.0% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $876,612,124 across 16 Diagnostics & Research names. MYGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,507,546 | $285,830,721 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
399,376 | $224,405,380 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
354,599 | $174,296,046 | |
| 4 | DGX |
Quest Diagnostics Inc
|
212,180 | $41,583,036 | |
| 5 | NEO |
Neogenomics Inc
|
3,452,587 | $25,618,195 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
149,586 | $25,510,395 | |
| 7 | GH |
Guardant Health, Inc.
|
234,376 | $21,649,311 | |
| 8 | A |
Agilent Technologies, Inc.
|
159,361 | $18,163,966 |
All Filings in MYGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $225,000 | 50,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $307,500 | 50,000 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||